RALOXIFENE GxP Raloxifene hydrochloride 60 mg tablets, blister pack

Negara: Australia

Bahasa: Inggris

Sumber: Department of Health (Therapeutic Goods Administration)

Bahan aktif:

raloxifene hydrochloride, Quantity: 60 mg

Tersedia dari:

MedTAS Pty Ltd

INN (Nama Internasional):

Raloxifene hydrochloride

Bentuk farmasi:

Tablet, film coated

Komposisi:

Excipient Ingredients: microcrystalline cellulose; crospovidone; magnesium stearate; glycine; colloidal anhydrous silica; polysorbate 80; povidone; titanium dioxide; hypromellose; Carnauba Wax; macrogol 400

Rute administrasi :

Oral

Unit dalam paket:

28 tablets

Jenis Resep:

(S4) Prescription Only Medicine

Indikasi Terapi:

Raloxifene is indicated for the prevention and treatment of osteoporosis in post-menopausal women.,Raloxifene is indicated for the reduction in the risk of invasive breast cancer in postmenopausal women with osteoporosis.Raloxifene is indicated for the reduction in the risk of invasive breast cancer in postmenopausal women at high risk of invasive breast cancer.

Ringkasan produk:

Visual Identification: White to off-white, oval, biconvex, film coated tablets with 'C' on one side and '12' on other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Status otorisasi:

Licence status A

Tanggal Otorisasi:

2014-01-14